2-hydroxyphytanic acid has been researched along with Cerebro-Hepato-Renal Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakobs, C; Schor, DS; ten Brink, HJ; van Roermund, CW; Wanders, RJ | 2 |
| Jakobs, C; Jansen, GA; Schor, DS; Verhoeven, NM; Wanders, RJ | 1 |
3 other study(ies) available for 2-hydroxyphytanic acid and Cerebro-Hepato-Renal Syndrome
| Article | Year |
|---|---|
Phytanic acid oxidation in man: identification of a new enzyme catalysing the formation of 2-ketophytanic acid from 2-hydroxyphytanic acid and its deficiency in the Zellweger syndrome.
Topics: Humans; Keto Acids; Liver; Microbodies; Oxidation-Reduction; Oxidoreductases; Phytanic Acid; Zellweger Syndrome | 1995 |
2-Hydroxyphytanic acid oxidase activity in rat and human liver and its deficiency in the Zellweger syndrome.
Topics: Alcohol Oxidoreductases; Animals; Humans; Liver; Male; Microbodies; Oxidation-Reduction; Phytanic Acid; Rats; Rats, Wistar; Zellweger Syndrome | 1994 |
Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver.
Topics: Biomarkers; Cell Fractionation; Coenzyme A; Decarboxylation; Fatty Acids; Humans; Liver; Microbodies; Microsomes; NAD; Phytanic Acid; Zellweger Syndrome | 1997 |